Published

Role of Psychedelics in Treatment-Resistant Depression.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The Psychiatric clinics of North America
Date: 2023-06-01
Source: PubMed
DOI: 10.1016/j.psc.2023.02.004
PubMed: 37149346

Authors

Kamal S Jha MK Radhakrishnan R

Watch author

Derived topics and classifications

psilocybin Depression Pharmacology Treatment-Resistant Depression Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psychedelics, entactogens and psychoplastogens for depression and related disorders.British journal of pharmacology · 2026-07-01 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 The need for publicly funded research on therapeutic use of psychedelic drugsWorld Psychiatry · 2021-05-18 Psychedelics: A new era of treatment?European psychiatry: the journal of the Association of European Psychiatrists · 2021-08-13 Retrospective Observational Study of Intensity Effects in Psychedelic-assisted TreatmentClinicalTrials.gov · 2025-10-02 Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in a Randomized, Placebo-controlled, Cross-over Trial in Healthy Participants (LPD-Study)ClinicalTrials.gov · 2025-03-27 Comparative Acute Effects of LSD, Psilocybin and Mescaline in a Random-Order Placebo-Controlled Cross-Over Study in Healthy SubjectsClinicalTrials.gov · 2024-01-24 The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy TrainingClinicalTrials.gov · 2025-04-14